Cited by 324Cancer survivorship and careCancer-related cognitive impairment studiesTreatment of Major Depression

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer center Community Clinical Oncology Program

Morrow, Gary R., Hickok, Jane T., Roscoe, Joseph A., Raubertas, Richard F., Andrews, Paul L.R., Flynn, Patrick J., Hynes, Harry E., Banerjee, Tarit K. +2 more·2003·Journal of Clinical Oncology

Abstract

Purpose: Fatigue and depression typically occur together in cancer patients, suggesting a common etiology, perhaps based on serotonin. This randomized clinical trial tested whether paroxetine, a selective serotonin reuptake inhibitor antidepressant known to modulate brain serotonin, would reduce fatigue in cancer patients and whether any reduction was related to depression. Patients and Methods: Cancer patients undergoing chemotherapy for the first time were assessed for fatigue. Of 704 patients who reported fatigue at their second chemotherapy cycle, 549 patients were randomly assigned to receive either 20 mg of oral paroxetine hydrochloride daily or placebo for 8 weeks. The assessments of fatigue and depression were performed at cycles 3 and 4 of chemotherapy. Results: A total of 244 patients treated with paroxetine and 235 patients treated with placebo provided assessable data. No difference was detected in fatigue between patient groups. At the end of the study, there was a difference between groups in the mean level of depression (Center for Epidemiologic Studies Depression scores, 12.0 v 14.8, respectively; P < .01). Conclusion: Paroxetine had no influence on fatigue in patients receiving chemotherapy. A possible explanation is that cancer-related fatigue does not involve a reduction in brain 5-HT levels.

Integrity signals

Registry

Crossref · 10.1200/jco.2003.04.070

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 26 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Morrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L. R., Flynn, P. J., Hynes, H. E., Banerjee, T. K., Kirshner, J. J., & King, D. K.
Affiliations
St George's, University of London (GB)
Venue
Journal of Clinical Oncology
Published
2003-12-15
Volume
21
Issue
24
Pages
4635-4641
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2118527171
Cited by
324
References
26
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 16 · 2017: 8 · 2016: 10 · 2015: 17 · 2014: 17 · 2013: 24 · 2012: 24
FWCI
5.86
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (U10CA037420, U10-CA37420)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
paroxetine, cancer-related fatigue, depression, chemotherapy-induced fatigue, selective serotonin reuptake inhibitors, serotonin, first-line chemotherapy, cancer patients
MeSH terms
Adult, Aged, Aged, 80 and over, Analysis of Variance, Depression, Double-Blind Method, Fatigue, Female, Humans, Male, Middle Aged, Neoplasms, Psychiatric Status Rating Scales, Chi-Square Distribution, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Paroxetine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review